¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"antigen drift"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antigenic drift
Ç׿øº¯ÀÌ
cardiovascular drift
½É(Àå)Ç÷°ü°èÀ¯µ¿, ½ÉÇ÷°ü°èÇ¥·ù
drift
1. °æÇâ, ÃßÀÌ 2. º¯ÀÌ
drift mutation
¿¬¼Óº¯ÀÌ
genetic drift
À¯Àüº¯ÀÌ
antigen
Ç׿ø
antigen analysis
Ç׿øºÐ¼®
antigen binding capacity
Ç׿ø°áÇÕ´É
antigen binding fragment
Ç׿ø°áÇÕºÎÀ§
antigen binding receptor
Ç׿ø°áÇÕ¼ö¿ëü
antigen capture assay
Ç׿øÆ÷È¹ÃøÁ¤
antigen competition
Ç׿ø°æÀï
antigen diffusion constant
Ç׿øÈ®»ê»ó¼ö
antigen excess
Ç׿ø°úÀ×
antigen excess zone
Ç׿ø°úÀ×±¸¿ª
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
drift
°æÇâ, ÃßÀÌ, º¯ÀÌ
antigen
Ç׿ø
antigen analysis
Ç׿øºÐ¼®
carcinoembryonic antigen
¾ÏÁ¾¹è¾ÆÇ׿ø
platelet-specific antigen
Ç÷¼ÒÆÇƯÀÌÇ׿ø
recombinant antigen
ÀçÁ¶ÇÕÇ׿ø
sequestered antigen
°Ý¸®Ç׿ø
somatic antigen
ü¼¼Æ÷Ç׿ø, ±ÕüÇ׿ø
surface antigen
Ç¥¸éÇ׿ø
tumor antigen
Á¾¾çÇ׿ø
antigen excess
Ç׿ø°úÀ×
antigen presentation
Ç׿øÀü´Þ
antigen receptor
Ç׿ø¼ö¿ëü
antigen-antibody reaction
Ç׿øÇ×ü¹ÝÀÀ
antigen-binding site
Ç׿ø°áÇÕºÎÀ§
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antigenic drift
Ç׿ø¼ÒÆøº¯ÀÌ
drift
°æÇâ, ÃßÀÌ, º¯ÀÌ
drift hypothesis
À̵¿°¡¼³
drift mutation
¿¬¼Óº¯ÀÌ
genetic drift
À¯ÀüÀÚº¯ÀÌ
antigen
Ç׿ø
accessible antigen
Á¢±Ù°¡´ÉÇ׿ø
antigen competition
Ç׿ø°æÀï
antigen excess
Ç׿ø°úÀ×
antigen mimicry
Ç׿øÀ¯»ç¼º
antigen modification
Ç׿øº¯È, Ç׿ø¼ö½Ä
antigen presentation
Ç׿øÀü´Þ
antigen receptor
Ç׿ø¼ö¿ëü
antigen recognition
Ç׿øÀÎÁö
antigen analysis
Ç׿øºÐ¼®
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antigen drift
Ç׿ø¼Òº¯ÀÌ.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antigenic drift
Ç׿ø¼Òº¯ÀÌ
antigenic drift, influenza viruses
Ç׿ø¼Òº¯ÀÌ(ù÷ê«á³Ü¨ì¶)
genetic drift
À¯ÀüÀû ºÎµ¿(¡Ý©ÔÑ).
ABH antigen
ABH Ç׿ø
B antigen
B Ç׿ø(ù÷ê«)
B cell antigen
B ¼¼Æ÷Ç׿ø
CA 19-9 antigen
CA 19-9 Ç׿ø
CA 50 antigen
CA 50 Ç׿ø
CA-2<
>
CA-2<<ÄÝ·ÎÀ̵åÇ׿ø>>
CD5 antigen
CD5 Ç׿ø
CEA(carcinoembryonic antigen)
žƼº¾ÏÇ׿ø
Cartwright antigen
īƮ¶óÀÌÆ®Ç׿ø
Cha antigen
Cha Ç׿ø
Chido (Ch") antigen
Chido(Ch") Ç׿ø
D antigen
D Ç׿ø
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antigen drift
Ç׿ø¼Òº¯ÀÌ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antigenic drift
Ç׿ø¼Òº¯ÀÌ
antigenic drift, influenza viruses
Ç׿ø¼Òº¯ÀÌ(ù÷ê«á³Ü¨ì¶)
drift hypothesis
À̵¿°¡¼³
drift mutation
¿¬¼Óº¯ÀÌ(ææáÙܨì¶).
drift, antigenic
Ç׿ø¼Òº¯ÀÌ
genetic drift
À¯ÀüÀû ºÎµ¿(¡Ý©ÔÑ).
capsular antigen =K. antigen
Çù¸·Ç׿ø(¡ù÷ê«).
a antigen
A Ç׿ø
accessible antigen
Á¢±Ù°¡´ÉÇ׿ø, ±ÙÁ¢Ç׿ø(ÐÎïÈù÷ê«).
analysis, antigen
Ç׿øºÐ¼®
anti-extractable nuclear antigen
Ç×-ÃßÃ⼺ ÇÙÇ׿ø
antigen
Ç׿ø(ù÷ê«)
antigen
Ç׿ø(ù÷ê«)
antigen
Ç׿ø
antigen antibody interaction
Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½